ABSTRACT
Bullous eruption Candidiasis (<2%) Cheilitis (<2%) Dermatitis (sic) (<2%) Diaphoresis (<2%) Eczema (sic) (<2%) Erythema (<2%) Erythema multiforme (1998): Garat H+, Ann Dermatol Venereol (French) 125, 42 Exanthems (<2%) Fixed eruption (2000): Smith KJ+, Cutis 66, 29 (2 cases) Folliculitis (<2%) Furunculosis Herpes simplex (<2%) Herpes zoster (<2%) Papulo-vesicular eruptions (2000): Smith KJ+, Cutis 66, 29 (2 cases) Photosensitivity (<2%) (1997): Winter AJ+, Genitourin Med 73, 323 Pigmentary changes (<2%) (2000): Smith KJ+, Cutis 66, 29 (2 cases) Pruritus (2000): Smith KJ+, Cutis 66, 29 (2 cases) Psoriasis
(2000): Bonfanti P+, J Acquir Immune Defic Syndr 23(3), 236 Rash (sic) (1.3%) Seborrheic dermatitis (<2%) Stevens-Johnson syndrome Ulcerations (<2%) Urticaria (<2%) Warts (<2%) Xerosis (<2%) (2000): Bonfanti P+, J Acquir Immune Defic Syndr 23(3), 236
Hair Hair-alopecia
Hair-changes (sic) (<2%)
Other Dysesthesia (<2%)
Dysgeusia (<2%) Gingivitis (<2%) Glossitis (<2%) Guillain-Barré syndrome Gynecomastia (2000): Bonfanti P+, J Acquir Immune Defic Syndr 23(3), 236 (1999): Donovan B+, Int J STD AIDS 10, 49 Headache Hyperesthesia (<2%) Lingual lesions (sic) (1998): Ruscin JM+, Ann Pharmacother 32, 1248 Lipodystrophy (2002): Reid S, Can Adv Drug Reaction Newsletter 12, 5 Oral ulceration (2.5%) Paresthesias (2.6%) Perioral paresthesias (2001): McMahon D+, Antivir Ther 6(2), 105 Stomatitis (<2%) Tendon xanthomata (2001): Leung N+, Diabetes 50(Suppl.2), 452 Xerostomia (<2%) *Note: Protease inhibitors cause dyslipidemia which includes elevated triglycerides
and cholesterol and redistribution of body fat centrally to produce the so-called ‘protease paunch,’ breast enlargement, facial atrophy, and ‘buffalo hump’
